Reference health

Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy

https://doi.org/10.1038/s41467-019-13204-3
CiteStamped reference-health badge
47/47 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 47 checked references that resolve
resolves10.1038/nrclinonc.2016.25
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
resolves10.1016/j.cell.2017.01.017
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
resolves10.1038/nature13954
PD-1 blockade induces responses by inhibiting adaptive immune resistance
resolves10.1158/1078-0432.CCR-13-3271
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy
resolves10.1038/nature14011
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
resolves10.1038/nrc3672
Thermal ablation of tumours: biological mechanisms and advances in therapy
resolves10.1158/1078-0432.CCR-15-1352
PD-1 Blockade Boosts Radiofrequency Ablation–Elicited Adaptive Immune Responses against Tumor
resolves10.1038/s41571-018-0046-7
Safety of combining radiotherapy with immune-checkpoint inhibition
resolves10.1080/21645515.2015.1009814
Clinically feasible approaches to potentiating cancer cell-based immunotherapies
resolves10.2217/hep-2016-0008
Hepatocellular carcinoma and immune therapy, from a clinical perspective; where are we?
resolves10.3389/fonc.2018.00315
Immuno-Oncology: Emerging Targets and Combination Therapies
resolves10.1016/S1386-6346(03)00207-9
Hepatocellular carcinoma with sarcomatous change arising after radiofrequency ablation for well-differentiated hepatocellular carcinoma
resolves10.3748/wjg.v10.i8.1137
Rapid progression of hepatocellular carcinoma after Radiofrequency Ablation
resolves10.1007/s10147-003-0328-6
Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma
resolves10.1016/j.jhep.2010.04.040
CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation
resolves10.1002/jso.21570
Radiofrequency ablation of colorectal liver metastases induces an inflammatory response in distant hepatic metastases but not in local accelerated outgrowth
resolves10.1016/j.canlet.2018.02.024
Insufficient radiofrequency ablation promotes proliferation of residual hepatocellular carcinoma via autophagy
resolves10.1007/s00262-013-1514-7
In vivo immunological antitumor effect of OK-432-stimulated dendritic cell transfer after radiofrequency ablation
resolves10.1016/j.immuni.2018.03.018
Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8+ T Cells
resolves10.3389/fimmu.2017.01106
Translational Significance for Tumor Metastasis of Tumor-Associated Macrophages and Epithelial–Mesenchymal Transition
resolves10.1016/j.celrep.2015.06.024
CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function
resolves10.1073/pnas.1113744109
Origins of tumor-associated macrophages and neutrophils
resolves10.1038/cmi.2017.135
The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?
resolves10.1136/gutjnl-2015-310514
Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma
resolves10.1148/radiol.2511072175
Radiofrequency Ablation Induces Antigen-presenting Cell Infiltration and Amplification of Weak Tumor-induced Immunity
resolves10.1053/j.gastro.2009.12.051
Radiofrequency Thermal Ablation for Hepatocellular Carcinoma Stimulates Autologous NK-Cell Response
resolves10.1136/gutjnl-2014-308286
Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation
resolves10.1148/radiol.10081634
Principles of and Advances in Percutaneous Ablation
resolves10.1186/1479-5876-10-230
After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma
resolves10.1111/cas.13191
Effect of a hypoxic microenvironment after radiofrequency ablation on residual hepatocellular cell migration and invasion
resolves10.1038/s41388-018-0169-4
Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation
resolves10.1097/SLA.0b013e3181a38ef5
Accelerated Perinecrotic Outgrowth of Colorectal Liver Metastases Following Radiofrequency Ablation is a Hypoxia-Driven Phenomenon
resolves10.1186/1479-5876-8-73
Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinoma
resolves10.1186/1479-5876-11-273
Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways
resolves10.1002/hep.26526
Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma
resolves10.1126/scitranslmed.aan3464
The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy
resolves10.1038/s41590-017-0022-x
Myeloid-derived suppressor cells coming of age
resolves10.1038/s41467-018-03966-7
Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation
resolves10.1053/j.seminoncol.2014.02.003
Myeloid-Derived Suppressor Cells in Cancer: Therapeutic, Predictive, and Prognostic Implications
resolves10.1158/1078-0432.CCR-15-0676
Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
resolves10.1038/nature20554
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
resolves10.1126/scitranslmed.3007974
Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
resolves10.1038/ncomms13050
Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers
resolves10.1038/s41467-017-01566-5
Host STING-dependent MDSC mobilization drives extrinsic radiation resistance
resolves10.1136/gutjnl-2017-313738
Targeting both tumour-associated CXCR2<sup>+</sup> neutrophils and CCR2<sup>+</sup> macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma
resolves10.1007/s00330-012-2561-8
Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors
resolves10.1016/S0221-0363(07)89927-6
Influence de la proximité des gros vaisseaux sur les résultats du traitement des carcinomes hépato-cellulaires par radiofréquence : une étude contrôlée
The 2 references without a DOI — listed, not checked
no DOI — not checkedPortolani, N. et al. Aggressive recurrence after radiofrequency ablation of liver neoplasms. Hepato-Gastroenterol. 50, 2179–2184 (2003).
no DOI — not checkedYoshimura, T., Liu, M., Chen, X., Li, L. & Wang, J. M. Crosstalk between tumor cells and macrophages in stroma renders tumor cells as the primary source of MCP-1/CCL2 in Lewis lung carcinoma. Front. Immunol. 6, 332 (2015).
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1038/s41467-019-13204-3"><img src="https://citestamp.com/citestamped/10.1038/s41467-019-13204-3/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1038/s41467-019-13204-3/badge.svg)](https://citestamp.com/citestamped/10.1038/s41467-019-13204-3)